시장보고서
상품코드
1149503

세계의 코골이 방지 기기 시장 예측 : 인사이트, 경쟁 상황, 시장(2027년)

Anti-Snoring Devices Market Insights, Competitive Landscape and, Market Forecast - 2027

발행일: | 리서치사: DelveInsight Business Research LLP | 페이지 정보: 영문 100 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 코골이 방지 기기 시장 규모는 2021년 14억 달러에 달했습니다. 시장은 2022년부터 2027년 예측 기간 동안 7.22%의 CAGR로 확대되었으며, 2027년 21억 3,000만 달러에 달할 것으로 예측되고 있습니다. 시장은 사람들 사이에서 비만이 증가하고 노인 인구 증가 등 다양한 요인에 의해 성장이 전망되고 있습니다.

세계의 코골이 방지 기기(Anti-Snoring Devices) 시장을 조사했으며 시장 주요 요약와 더불어 장치 유형별, 외과수기별, 최종 사용자별, 지역별 동향 및 시장에 진입하는 기업 프로필 등을 제공합니다.

목차

제1장 코골이 방지 기기 시장 리포트 인트로덕션

제2장 코골이 방지 기기 시장 주요 요약

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 코골이 방지 기기 시장 주요 요인 분석

  • 코골이 방지 기기 시장 촉진 요인
  • 코골이 방지 기기 시장 억제 요인과 과제
  • 코골이 방지 기기 시장 기회

제5장 코골이 방지 기기 시장에 관한 포터의 5가지 경쟁요인 분석

제6장 코골이 방지장치 시장 COVID-19의 영향 분석

제7장 코골이 방지 기기 시장 레이아웃

  • 장치 유형별
  • 외과수기별
  • 최종 사용자별
  • 지역별

제8장 코골이 방지 기기 시장 세계의 기업 점유율 분석-주요 기업 3-5사

제9장 코골이 방지장치 시장 기업 및 제품 프로필

  • Fisher& Paykel Healthcare Limited
  • Koninklijke Philips NV
  • ResMed.
  • Tomed GmbH.
  • Apnea Sciences
  • Rotech Healthcare Inc.
  • Meditas
  • Mitsui Chemicals, Inc.
  • SomnoMed
  • The Pure Sleep Company
  • GSK plc.
  • Airway Management.
  • HIVOX BIOTEK INC.
  • Ripsnore
  • Oniris
  • ZYPPAH
  • MPowrx(TM) Health and Wellness Products
  • Contour Products, Inc.
  • Sleeping Well LLC
  • Inovatives Health Technologies Inc.

제10장 KOL 견해

제11장 프로젝트 접근

제12장 DelveInsight 정보

제13장 면책사항과 문의

NJH 22.11.18

ANTI-SNORING DEVICES MARKET BY DEVICE TYPE (MANDIBULAR ADVANCEMENT DEVICES [MAD], TONGUE STABILIZING DEVICES [TSD], CONTINUOUS POSITIVE AIRWAY PRESSURE [CPAP] DEVICES, AND OTHERS), BY SURGICAL PROCEDURE (UVULOPALATOPHARYNGOPLASTY [UPPP], SOMNOPLASTY, PILLAR PROCEDURE, TONSILLECTOMY, RADIOFREQUENCY PALATOPLASTY, AND OTHERS), BY END-USER (HOSPITALS, SLEEP THERAPY CLINICS, HOMECARE, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO GROW AT A STEADY CAGR FORECAST TILL 2027 OWING TO INCREASING OBESITY AND ELDERLY POPULATION ACROSS THE GLOBE AND THE LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS IN THE MARKET.

The global anti-snoring devices market was valued at USD 1.40 billion in 2021, growing at a CAGR of 7.22% during the forecast period from 2022 to 2027 to reach USD 2.13 billion by 2027. The anti-snoring devices market is witnessing positive growth owing to various factors such as the increasing obesity among the people and rising number of elderly population. Also, the increasing smoking and alcohol consumption, the rising prevalence of sleep apnea and the technological advancements in the market pertaining to the anti-snoring devices along with the product launches and approvals, and others are offering prominent opportunities for the market growth. Therefore, the market for anti-snoring devices are estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.

ANTI-SNORING DEVICES MARKET DYNAMICS:

One of the main drivers of the anti-snoring devices market is the increasing burden of obesity and overweight among the people across the globe.

For instance, according to the data published by the World Health Organization (WHO) in 2021, stated that in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese. Also, the source concluded that almost half of the children under 5 years who were overweight or obese in 2019 lived in Asia. The obesity is more likely to cause snoring and obstructive sleep apnea as neck fat compresses the upper airway, particularly when lying down, making snoring much more likely. Also, the central obesity, where fat is found around the midriff and chest, also worsens snoring and sleep apnea. Thus, the obesity will increase the prevalence of obstructive sleep apnea and snoring, ultimately increasing the demand of snoring management and treatment devices in the upcoming years.

Further, the increasing geriatric burden across the globe will aid in propelling the market of anti-snoring devices during the study period (2022 - 2027). As per WHO 2022, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years, across the globe. The data provided by the above mentioned source estimated that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion, in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The number of persons aged 80 years or older was also provided by the same source, which is expected to triple between 2020 and 2050 to reach 426 million, globally. The geriatric people are more prone to snoring and sleep apnea as with aging, the apparent weakening and loss of tone of upper airway muscles during sleep predisposes to airway obstruction that leads to snoring and sleep apnea.

Thus, the escalating burden of elderly population across the globe will increase the demand of anti-snoring devices in the market.

Therefore, the factors stated above collectively will drive the overall anti-snoring devices market during the forecast period from 2022-2027.

However, high costs of custom-made oral devices, poor efficacy and lack of scientific validation of the anti-snoring devices among people and physicians, and others, can impede the global anti-snoring devices market growth.

The COVID-19 epidemic has moderately impacted the anti-snoring devices market as the pandemic led to a fall in sales of anti-snoring devices. The fall in sales can be attributed to a reduced number of elective surgeries being carried out. Moreover, severe disruption in the supply chain, shortage of raw material and other resources due to the lockdowns and restrictions, the manufacturing of the devices was halted. The pandemic also resulted in fewer hospital visits by the patients owing to the lockdown impositions. All of this led to a slightly negative impact on the market. However, with the ease of lockdown restrictions, upturn of resources and supply chain, the administration of vaccine among the public, the increasing hospitalization number for surgical methods

, and with the increasing demand of devices through e-commerce platforms, the market of anti-snoring devices picked up the momentum again and is expected to do the same in the upcoming years.

ANTI-SNORING DEVICES MARKET SEGMENT ANALYSIS:

Anti-Snoring Devices Market By Device Type (Mandibular Advancement Devices [MAD], Tongue Stabilizing Devices [TSD], Continuous Positive Airway Pressure [CPAP] Devices, and Others), Surgical Procedure (Uvulopalatopharyngoplasty [UPPP], Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Others), End-User (Hospitals, Sleep Therapy Clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of the anti-snoring devices, the continuous positive airway pressure (CPAP) market is expected to have a significant revenue share in the year 2021. This was primarily owing to the increasing demand of CPAP device during the pandemic.

Continuous positive airway pressure (CPAP) devices are used in airway blockages to open up the blocked airways by pushing air into them. The CPAP has a pump that controls the air pressure in the system and consists of a tube carrying air toward the mask attached to the nose and mouth. CPAP devices help ease the functioning of the airway and help the person get a night of sound sleep, increasing their demand. Thus, the demand for CPAP machines and masks increased since CPAP devices shows beneficial effects on managing the symptoms of COVID-19, such as ease of breathing and chest congestion.

Further, the increasing launches in the market by the key players aids in propelling the demand of CPAP in the market. For instance, in June 2019, InnAccel introduced SAANS, a CPAP system in the market. It is the world's first infrastructure-independent, portable, and neonatal CPAP system that provides constant air flow, preventing the airway from collapsing. Also, it eliminates the vibration of tissue that causes snoring.

Also, in August 2021, ResMed released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea and snoring.

Thus, due to the interplay of all the factors mentioned above, this can result in the rising demand for continuous positive airway pressure, which in turn would provide a conducive growth environment for overall anti-snoring devices market during the market forecast 2022-2027.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL ANTI-SNORING DEVICES MARKET:

Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2021 and is expected to do the same during the forecast period from 2022-2027.

Factors such as the increasing prevalence of sleep apnea among the people in the region, and the rising obesity, and elderly population will spur the demand of the anti-soring devices in the region. Further, the growing consumer awareness regarding the importance of snoring management devices, presence of key players, and other are anticipated to drive the market of anti-snoring devices in the North America during the forecast period of 2022 - 2027.

For instance, as per the latest data published by the National Center for Biotechnology Information, 1 in 15 people present with moderate to severe symptoms of the sleep disorder, in the United States. Also, obstructive sleep apnea (OSA) may affect as many as 37% of adults in North, Central and South America, according to the latest study Associated Professional Sleep Societies.

Further, according to the data of Sleep Foundation (2019), in the United States, in 2019, about 57% of the men and 40% of the women were living with the snoring condition. Thus, from the above-mentioned figures it can be concluded that the prevalence of sleep apnea and snoring is quite high in the United States, leading to the increased demand of anti-snoring devices in the market.

Moreover, as per the Centers for Disease Control and Prevention, 2019, all US states and territories have an obesity rate of at least 20%, in 2019. The source also stated that about 18.5% of children ages 2 to 19 were considered as obese in the United States, in 2019. The increasing obesity among the people in the region will increase the demand of anti-snoring devices as the obese and overweight people are more prone to snoring due to the presence of excessive fat accumulation near neck or chest which may cause narrowing of airways, causing snoring, ultimately leading to the increased demand of snoring management and treatment devices, thereby propelling the overall market of anti-snoring devices in the North America during 2022 - 2027.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the anti-snoring devices.

ANTI-SNORING DEVICES MARKET KEY PLAYERS:

Some of the key market players operating in the anti-snoring devices market include Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., ResMed., Tomed GmbH., Apnea Sciences, Rotech Healthcare Inc., Meditas, Mitsui Chemicals, Inc., SomnoMed, The Pure Sleep Company, GSK plc., Airway Management., HIVOX BIOTEK INC., Ripsnore, Oniris, ZYPPAH, Mpowrx™ Health and Wellness Products, Contour Products, Inc., Sleeping Well LLC, Inovatives Health Technologies Inc., and others.

RECENT DEVELOPMENTAL ACTIVITIES IN THE ANTI-SNORING DEVICES MARKET:

  • In February 2021, the US FDA approved the commercialization of a prescription-only anti-snoring device, eXciteOSA, developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue.
  • In September 2020, ResMed Inc. introduced the AirTouch N20 CPAP, a nasal mask featured with a memory foam cushion. It is based on the company's patented ultraSoft memory foam cushion technology.

KEY TAKEAWAYS FROM THE ANTI-SNORING DEVICES MARKET REPORT STUDY

  • Market size analysis for current anti-snoring devices (2021), and market forecast for 5 years (2022-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the anti-snoring devices market
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the global Anti-Snoring Devices market
  • Various opportunities are available for the other competitor in the anti-snoring devices market space.
  • What are the top-performing segments in 2021? How these segments will perform in 2027.
  • Which are the top-performing regions and countries in the current anti-snoring devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for anti-snoring devices market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS ANTI-SNORING DEVICES MARKET REPORT STUDY

  • Anti-Snoring devices providers
  • Research organizations and consulting companies
  • Anti-Snoring devices market-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in anti-snoring devices market
  • Various end-users who want to know more about the anti-snoring devices and the latest technological developments in the anti-snoring devices market

FREQUENTLY ASKED QUESTIONS FOR ANTI-SNORING DEVICES MARKET:

1. What are anti-snoring devices?

Anti-snoring treatment devices refers to the type of equipment utilized to prevent snoring. Snoring is characterized as a vibration of the respiratory tract due to obstruction in the airway flow.

2. What is the market for global anti-snoring devices?

The global anti-snoring devices market was valued at USD 1.40 billion in 2021, growing at a CAGR of 7.22% during the forecast period from 2022 to 2027 to reach USD 2.13 billion by 2027.

3. What are the drivers for the global anti-snoring devices market?

The anti-snoring devices is witnessing an affirmative market growth due to the factors such as increasing obesity among the people and rising burden of geriatric population. Also, the increasing smoking and alcohol consumption, rising prevalence of sleep apnea, technological advancements pertaining to anti-snoring devices along with the product launches and approvals, and others will drive the market of anti-snoring devices in the forecast period.

4. Who are the key players operating in the anti-snoring devices market?

Some of the key market players operating in the anti-snoring devices include Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., ResMed., Tomed GmbH., Apnea Sciences, Rotech Healthcare Inc., Meditas, Mitsui Chemicals, Inc., SomnoMed, The Pure Sleep Company, GSK plc., Airway Management., HIVOX BIOTEK INC., Ripsnore, Oniris, ZYPPAH, Mpowrx™ Health and Wellness Products, Contour Products, Inc., Sleeping Well LLC, Inovatives Health Technologies Inc., and others

5. Which region has the highest share in anti-snoring devices market?

North America is expected to dominate the global anti-snoring devices. Factors contributing to the growth are the increasing prevalence of sleep apnea among the people, rising obesity, growing consumer awareness regarding the importance of snoring management devices, and others, are contributing to the growth of the anti-snoring devices in the North America region.

Table of Contents

1. Anti-Snoring Devices Market Report Introduction

2. Anti-Snoring Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The US
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Anti-Snoring Devices Market Key Factors Analysis

  • 4.1 Anti-Snoring Devices Market Drivers
    • 4.1.1 Increase in Obesity and Geriatric Population
    • 4.1.2 Increasing Smoking and Alcohol Consumption
    • 4.1.3 Rising Prevalence of Sleep Apnea
    • 4.1.4 Technological Advancements in Anti-Snoring Devices
  • 4.2 Anti-Snoring Devices Market Restraints And Challenges
    • 4.2.1 High Costs of Custom-made Oral Devices
    • 4.2.2 Poor Efficacy and Lack of Scientific Validation of the Anti-snoring Devices
  • 4.3 Anti-Snoring Devices Market Opportunities
    • 4.3.1 Increasing Awareness in the Developing and Under-Developing Markets
    • 4.3.2 Decreasing Social Stigma Associated with Snoring among the People

5. Anti-Snoring Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Anti-Snoring Devices Market

7. Anti-Snoring Devices Market Layout

  • 7.1 By Device Type
    • 7.1.1 Mandibular Advancement Devices (MAD)
    • 7.1.2 Tongue Stabilizing Devices (TSD)
    • 7.1.3 Continuous Positive Airway Pressure (CPAP) Devices
    • 7.1.4 Others
  • 7.2 By Surgical Procedure
  • 7.2. 1 Uvulopalatopharyngoplasty (UPPP)
    • 7.2.2 Somnoplasty
    • 7.2.3 Pillar Procedure
    • 7.2.4 Tonsillectomy
    • 7.2.5 Radiofrequency Palatoplasty
    • 7.2.6 Others
  • 7.3 By End-User
    • 7.3.1 Hospitals
    • 7.3.2 Sleep Therapy Clinics
    • 7.3.3 Homecare
    • 7.3.4 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.1.2 Canada Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.1.3 Mexico Anti-Snoring Devices Market Size in USD Million (2019-2027)
    • 7.4.2 Europe
      • 7.4.2.1 France Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.2.2 Germany Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.2.3 United Kingdom Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.2.4 Italy Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.2.5 Spain Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.2.6 Rest of Europe Anti-Snoring Devices Market Size in USD Million (2019-2027)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.3.2 Japan Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.3.3 India Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.3.4 Australia Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.3.5 South Korea Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.3.6 Rest of Asia Pacific Anti-Snoring Devices Market Size in USD Million (2019-2027)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.4.2 Africa Anti-Snoring Devices Market Size in USD Million (2019-2027)
      • 7.4.4.3 South America Anti-Snoring Devices Market Size in USD Million (2019-2027)

8. Anti-Snoring Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Anti-Snoring Devices Market Company and Product Profiles

  • 9.1 Fisher & Paykel Healthcare Limited.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2 Koninklijke Philips N.V.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3 ResMed.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4 Tomed GmbH.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5 Apnea Sciences
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6 Rotech Healthcare Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7 Meditas
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8 Mitsui Chemicals, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9 SomnoMed
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10 The Pure Sleep Company
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11 GSK plc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12 Airway Management.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13 HIVOX BIOTEK INC.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14 Ripsnore
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15 Oniris
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16 ZYPPAH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17 MPowrx™ Health and Wellness Products
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18 Contour Products, Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19 Sleeping Well LLC
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20 Inovatives Health Technologies Inc.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제